While it has been repeatedly emphasized that Baiyunshan blue root is not a special drug to combat the epidemic, but the species in the people's cognition, is the anti-epidemic traditional Chinese medicine, as long as there is an epidemic, the price of and demand for blue root will appear larger fluctuations. On the one hand, it can be seen from the fast-selling price rise of Panax quinquefolium seeds; on the other hand, from the first half of 2021, more than 30 new domestic Panax quinquefolium production bases, Zunyi, Guizhou, Qiqihar, Heilongjiang, Jixi, and Hegang, etc., as well as Nanyang Xichuan, Henan, and Neihuang County, Anyang, etc., have been large-scale planting, but also can be predicted that Panax quinquefolium expansion speed. According to the statistics of the Tiandi Yuntu traditional Chinese medicine industry big data platform, the output of Panax quinquefolium in 2020 is 54,200 tons, an increase of more than 25% compared with the production capacity of 2019, but affected by the successive rise in grain prices, especially corn prices, the expansion of Panax quinquefolium planting area in 2021 will be slowed down.